Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.
Leotta S, Pirosa MCristina, Markovic U, Scalise L, Bulla A, Sapienza G, Di Giorgio MAnn, Martino EAntonia, Pelle ACurto, Leotta V, et al. Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy. Chemotherapy. 2019:1-4.